Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1995 Aug;39(8):1696–1699. doi: 10.1128/aac.39.8.1696

Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata.

T Parkinson 1, D J Falconer 1, C A Hitchcock 1
PMCID: PMC162810  PMID: 7486903

Abstract

We report on the mechanism of fluconazole resistance in Candida glabrata from a case of infection in which pre- and posttreatment isolates were available for comparison. The resistant, posttreatment isolate was cross-resistant to ketoconazole and itraconazole, in common with other azole-resistant yeasts. Resistance was due to reduced levels of accumulation of [3H]fluconazole rather than to changes at the level of ergosterol biosynthesis. Studies with metabolic or respiratory inhibitors showed that this phenomenon was a consequence of energy-dependent drug efflux, as opposed to a barrier to influx. Since energy-dependent efflux is a characteristic of multidrug resistance in bacteria, yeasts, and mammalian cells, we investigated the possibility that fluconazole resistance is mediated by a multidrug resistance-type mechanism. Benomyl, a substrate for the Candida albicans multidrug resistance protein, showed competition with fluconazole for efflux from resistance C. glabrata isolates, consistent with a common efflux mechanism for these compounds. By contrast, other standard substrates or inhibitors of multidrug resistance proteins had no effect on fluconazole efflux. In conclusion, we have identified energy-dependent efflux of fluconazole, possibly via a multidrug resistance-type transporter, as the mechanism of resistance to fluconazole in C. glabrata.

Full Text

The Full Text of this article is available as a PDF (262.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ambudkar S. V., Lelong I. H., Zhang J., Cardarelli C. O., Gottesman M. M., Pastan I. Partial purification and reconstitution of the human multidrug-resistance pump: characterization of the drug-stimulatable ATP hydrolysis. Proc Natl Acad Sci U S A. 1992 Sep 15;89(18):8472–8476. doi: 10.1073/pnas.89.18.8472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ben-Yaacov R., Knoller S., Caldwell G. A., Becker J. M., Koltin Y. Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene. Antimicrob Agents Chemother. 1994 Apr;38(4):648–652. doi: 10.1128/aac.38.4.648. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Boiron P., Drouhet E., Dupont B., Improvisi L. Entry of ketoconazole into Candida albicans. Antimicrob Agents Chemother. 1987 Feb;31(2):244–248. doi: 10.1128/aac.31.2.244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cass C. E., Janowska-Wieczorek A., Lynch M. A., Sheinin H., Hindenburg A. A., Beck W. T. Effect of duration of exposure to verapamil on vincristine activity against multidrug-resistant human leukemic cell lines. Cancer Res. 1989 Nov 1;49(21):5798–5804. [PubMed] [Google Scholar]
  5. Gottesman M. M., Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem. 1993;62:385–427. doi: 10.1146/annurev.bi.62.070193.002125. [DOI] [PubMed] [Google Scholar]
  6. Higgins C. F. ABC transporters: from microorganisms to man. Annu Rev Cell Biol. 1992;8:67–113. doi: 10.1146/annurev.cb.08.110192.000435. [DOI] [PubMed] [Google Scholar]
  7. Hitchcock C. A. Cytochrome P-450-dependent 14 alpha-sterol demethylase of Candida albicans and its interaction with azole antifungals. Biochem Soc Trans. 1991 Aug;19(3):782–787. doi: 10.1042/bst0190782. [DOI] [PubMed] [Google Scholar]
  8. Hitchcock C. A., Pye G. W., Troke P. F., Johnson E. M., Warnock D. W. Fluconazole resistance in Candida glabrata. Antimicrob Agents Chemother. 1993 Sep;37(9):1962–1965. doi: 10.1128/aac.37.9.1962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hitchcock C. A. Resistance of Candida albicans to azole antifungal agents. Biochem Soc Trans. 1993 Nov;21(4):1039–1047. doi: 10.1042/bst0211039. [DOI] [PubMed] [Google Scholar]
  10. Kanazawa S., Driscoll M., Struhl K. ATR1, a Saccharomyces cerevisiae gene encoding a transmembrane protein required for aminotriazole resistance. Mol Cell Biol. 1988 Feb;8(2):664–673. doi: 10.1128/mcb.8.2.664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lambert B., Le Pecq J. B. Effect of mutation, electric membrane potential, and metabolic inhibitors on the accessibility of nucleic acids to ethidium bromide in Escherichia coli cells. Biochemistry. 1984 Jan 3;23(1):166–176. doi: 10.1021/bi00296a027. [DOI] [PubMed] [Google Scholar]
  12. Leonard P. J., Rathod P. K., Golin J. Loss of function mutation in the yeast multiple drug resistance gene PDR5 causes a reduction in chloramphenicol efflux. Antimicrob Agents Chemother. 1994 Oct;38(10):2492–2494. doi: 10.1128/aac.38.10.2492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Miyauchi S., Komatsubara M., Kamo N. In archaebacteria, there is a doxorubicin efflux pump similar to mammalian P-glycoprotein. Biochim Biophys Acta. 1992 Oct 5;1110(2):144–150. doi: 10.1016/0005-2736(92)90351-l. [DOI] [PubMed] [Google Scholar]
  14. Neyfakh A. A. The multidrug efflux transporter of Bacillus subtilis is a structural and functional homolog of the Staphylococcus NorA protein. Antimicrob Agents Chemother. 1992 Feb;36(2):484–485. doi: 10.1128/aac.36.2.484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Pfaller M. A., Rinaldi M. G., Galgiani J. N., Bartlett M. S., Body B. A., Espinel-Ingroff A., Fromtling R. A., Hall G. S., Hughes C. E., Odds F. C. Collaborative investigation of variables in susceptibility testing of yeasts. Antimicrob Agents Chemother. 1990 Sep;34(9):1648–1654. doi: 10.1128/aac.34.9.1648. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ramu A., Pollard H. B., Rosario L. M. Doxorubicin resistance in P388 leukemia--evidence for reduced drug influx. Int J Cancer. 1989 Sep 15;44(3):539–547. doi: 10.1002/ijc.2910440328. [DOI] [PubMed] [Google Scholar]
  17. Rex J. H., Rinaldi M. G., Pfaller M. A. Resistance of Candida species to fluconazole. Antimicrob Agents Chemother. 1995 Jan;39(1):1–8. doi: 10.1128/aac.39.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ryley J. F., Wilson R. G., Barrett-Bee K. J. Azole resistance in Candida albicans. Sabouraudia. 1984;22(1):53–63. [PubMed] [Google Scholar]
  19. Servos J., Haase E., Brendel M. Gene SNQ2 of Saccharomyces cerevisiae, which confers resistance to 4-nitroquinoline-N-oxide and other chemicals, encodes a 169 kDa protein homologous to ATP-dependent permeases. Mol Gen Genet. 1993 Jan;236(2-3):214–218. doi: 10.1007/BF00277115. [DOI] [PubMed] [Google Scholar]
  20. Spoelstra E. C., Westerhoff H. V., Pinedo H. M., Dekker H., Lankelma J. The multidrug-resistance-reverser verapamil interferes with cellular P-glycoprotein-mediated pumping of daunorubicin as a non-competing substrate. Eur J Biochem. 1994 Apr 1;221(1):363–373. doi: 10.1111/j.1432-1033.1994.tb18748.x. [DOI] [PubMed] [Google Scholar]
  21. Tang-Wai D. F., Brossi A., Arnold L. D., Gros P. The nitrogen of the acetamido group of colchicine modulates P-glycoprotein-mediated multidrug resistance. Biochemistry. 1993 Jun 29;32(25):6470–6476. doi: 10.1021/bi00076a022. [DOI] [PubMed] [Google Scholar]
  22. Tennent J. M., Lyon B. R., Midgley M., Jones I. G., Purewal A. S., Skurray R. A. Physical and biochemical characterization of the qacA gene encoding antiseptic and disinfectant resistance in Staphylococcus aureus. J Gen Microbiol. 1989 Jan;135(1):1–10. doi: 10.1099/00221287-135-1-1. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES